ES2187380A1 - Mejoras introducidas en productos destinados al consumo humano o animal. - Google Patents

Mejoras introducidas en productos destinados al consumo humano o animal.

Info

Publication number
ES2187380A1
ES2187380A1 ES200102540A ES200102540A ES2187380A1 ES 2187380 A1 ES2187380 A1 ES 2187380A1 ES 200102540 A ES200102540 A ES 200102540A ES 200102540 A ES200102540 A ES 200102540A ES 2187380 A1 ES2187380 A1 ES 2187380A1
Authority
ES
Spain
Prior art keywords
human
animal consumption
products
hydrophobic agent
products intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES200102540A
Other languages
English (en)
Inventor
Sanchez Juan Balufo
Grau Jose Ramon Tico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES200102540A priority Critical patent/ES2187380A1/es
Priority to EP02380235A priority patent/EP1323414A3/fr
Publication of ES2187380A1 publication Critical patent/ES2187380A1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mejoras introducidas en productos destinados al consuno humano o animal. Las mejoras objeto de la invención contemplan que los productos en cuestión puedan presentarse en forma de gránulos o partículas constituidos por materias activas solas, o asociadas a otras, o en combinación con excipientes, y por un agente hidrófobo sustancialmente insoluble en agua, en estado sólido, con un punto de fusión comprendido entre 10 y 80 grados centígrados, manteniendo aislada la materia activa e impidiendo que inicie su actividad hasta el momento en que se produzca la fusión del agente hidrófobo.
ES200102540A 2001-11-16 2001-11-16 Mejoras introducidas en productos destinados al consumo humano o animal. Pending ES2187380A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200102540A ES2187380A1 (es) 2001-11-16 2001-11-16 Mejoras introducidas en productos destinados al consumo humano o animal.
EP02380235A EP1323414A3 (fr) 2001-11-16 2002-11-15 Améliorations introduites dans des produits destinés à la consommation humaine ou animale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102540A ES2187380A1 (es) 2001-11-16 2001-11-16 Mejoras introducidas en productos destinados al consumo humano o animal.

Publications (1)

Publication Number Publication Date
ES2187380A1 true ES2187380A1 (es) 2003-06-01

Family

ID=8499472

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200102540A Pending ES2187380A1 (es) 2001-11-16 2001-11-16 Mejoras introducidas en productos destinados al consumo humano o animal.

Country Status (2)

Country Link
EP (1) EP1323414A3 (es)
ES (1) ES2187380A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178199A1 (en) * 2004-03-04 2007-08-02 Marcel Minor Granulate containing a functional food ingredient and method for the manufacture thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511584A (en) * 1983-05-31 1985-04-16 Scm Corporation Particulate food acidulant
US4537784A (en) * 1983-05-31 1985-08-27 Scm Corporation Process of preparing a particulate food acidulant
EP0275358A1 (en) * 1986-12-15 1988-07-27 Ohkawara Kakohki Co., Ltd. Microcapsules and process for producing them
WO1989000819A1 (en) * 1987-07-29 1989-02-09 The Nutrasweet Company Self stabilized dipeptide sweeteners
US5190775A (en) * 1991-05-29 1993-03-02 Balchem Corporation Encapsulated bioactive substances

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597685B2 (ja) * 1978-10-06 1984-02-20 理研ビタミン株式会社 ビタミン製剤の製造法
JP2668880B2 (ja) * 1987-06-23 1997-10-27 日本油脂株式会社 被覆アミノ酸類の製造方法
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
TW209174B (es) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JP3122510B2 (ja) * 1992-02-18 2001-01-09 日清製粉株式会社 ビタミンｃ顆粒
US5360614A (en) * 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
US5807594A (en) * 1997-02-26 1998-09-15 Ducoa, L.P. Method for enhancing feed efficiency in ruminants with an encapsulating choline composition
US5976598A (en) * 1997-11-04 1999-11-02 Nabisco, Inc. Physically coated cellulose as low calorie flour replacements
US6355274B1 (en) * 1999-12-15 2002-03-12 Mcneil-Ppc, Inc. Encapsulated long chain alcohols
US6251478B1 (en) * 1999-12-22 2001-06-26 Balchem Corporation Sensitive substance encapsulation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511584A (en) * 1983-05-31 1985-04-16 Scm Corporation Particulate food acidulant
US4537784A (en) * 1983-05-31 1985-08-27 Scm Corporation Process of preparing a particulate food acidulant
EP0275358A1 (en) * 1986-12-15 1988-07-27 Ohkawara Kakohki Co., Ltd. Microcapsules and process for producing them
WO1989000819A1 (en) * 1987-07-29 1989-02-09 The Nutrasweet Company Self stabilized dipeptide sweeteners
US5190775A (en) * 1991-05-29 1993-03-02 Balchem Corporation Encapsulated bioactive substances

Also Published As

Publication number Publication date
EP1323414A2 (fr) 2003-07-02
EP1323414A3 (fr) 2003-10-22

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
IL145475A0 (en) Compounds that inhibit impdh enzyme and pharmaceutical compositions containing the same
NO20013883L (no) Frysetörket middel inneholdende paramylon, samt fremstilling og anvendelse derav
NL1013685A1 (nl) Verknopingsmiddel voor fotolaklaag en fotolaklaagsamenstelling welke deze omvat.
NL1026892A1 (nl) ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie.
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
HUP0202501A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
AU2003280087A8 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
HUP0302337A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ZA200102589B (en) Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof.
MA26802A1 (fr) Derives de streptogramine, leur preparation et les compositions qui les contiennent.
PT1217898E (pt) Caramelos duros com estabilidade de armazenamento melhorada
MX2007001931A (es) Aditivo alimentario.
ES2187380A1 (es) Mejoras introducidas en productos destinados al consumo humano o animal.
PT1017667E (pt) 2-amino-6-metil-7-acetil-tetralina e composicoes farmaceuticas para a prevencao e para o tratamento terapeutico de patologias inflamatorias e/ou de natureza autoimunitaria

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030601

Kind code of ref document: A1

FC2A Grant refused

Effective date: 20060629